Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Norbert Bischofberger

    - PMLiVE

    Gilead’s Yescarta shows benefits for patients with large B-cell lymphoma

    This is the most common type of non-Hodgkin lymphoma worldwide

    - PMLiVE

    Gilead reports Trodelvy breast cancer trial missed primary survival endpoint

    The drug treatment is being evaluated in several ongoing phase 3 trials

    - PMLiVE

    Sanofi unveils $20bn US investment to boost R&D and manufacturing presence

    The company is the latest major drugmaker to announce a significant investment in the country

    - PMLiVE

    Gilead shares promising phase 3 results for Trodelvy plus Keytruda in aggressive breast cancer

    Triple-negative breast cancer accounts for approximately 15% of all cases of the disease

    Biogen Idec building

    Biogen unveils plans for new global headquarters and R&D hub in US

    The company is expecting to relocate its Cambridge-based employees to the new site in 2028

    - PMLiVE

    AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

    The funds will go towards a new global research and development centre in Beijing’s BioPark

    - PMLiVE

    Gilead’s seladelpar recommended by CHMP to treat primary biliary cholangitis

    The rare liver disease affects approximately 15 per 100,000 people in Europe

    - PMLiVE

    Gilead’s Livdelzi receives FDA accelerated approval to treat primary biliary cholangitis

    The company gained access to the drug through its $4.3bn acquisition of CymaBay in March

    - PMLiVE

    Ipsen announces launch of new UK headquarters in London life sciences community

    The Paddington site will serve as one of the company’s three global hubs

    - PMLiVE

    ABPI publishes manifesto for government to accelerate UK life sciences industry

    The trade association has called on political parties to commit to three broad goals and requirements

    - PMLiVE

    UK’s Autumn Budget details measures to boost life sciences sector

    The new budget will aim to advance research and manufacturing in the UK

    - PMLiVE

    ABPI report shows improvement in UK industry clinical trial performance

    The data showed a 15% increase in annual recruitment to UK industry clinical trials

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links